These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

347 related items for PubMed ID: 15576777

  • 1. Isolation of Escherichia coli bacteriophages from the stool of pediatric diarrhea patients in Bangladesh.
    Chibani-Chennoufi S, Sidoti J, Bruttin A, Dillmann ML, Kutter E, Qadri F, Sarker SA, Brüssow H.
    J Bacteriol; 2004 Dec; 186(24):8287-94. PubMed ID: 15576777
    [Abstract] [Full Text] [Related]

  • 2. Genome analysis of phage JS98 defines a fourth major subgroup of T4-like phages in Escherichia coli.
    Zuber S, Ngom-Bru C, Barretto C, Bruttin A, Brüssow H, Denou E.
    J Bacteriol; 2007 Nov; 189(22):8206-14. PubMed ID: 17693496
    [Abstract] [Full Text] [Related]

  • 3. In vitro and in vivo bacteriolytic activities of Escherichia coli phages: implications for phage therapy.
    Chibani-Chennoufi S, Sidoti J, Bruttin A, Kutter E, Sarker S, Brüssow H.
    Antimicrob Agents Chemother; 2004 Jul; 48(7):2558-69. PubMed ID: 15215109
    [Abstract] [Full Text] [Related]

  • 4. Oral Phage Therapy of Acute Bacterial Diarrhea With Two Coliphage Preparations: A Randomized Trial in Children From Bangladesh.
    Sarker SA, Sultana S, Reuteler G, Moine D, Descombes P, Charton F, Bourdin G, McCallin S, Ngom-Bru C, Neville T, Akter M, Huq S, Qadri F, Talukdar K, Kassam M, Delley M, Loiseau C, Deng Y, El Aidy S, Berger B, Brüssow H.
    EBioMedicine; 2016 Feb; 4():124-37. PubMed ID: 26981577
    [Abstract] [Full Text] [Related]

  • 5. T4 phages against Escherichia coli diarrhea: potential and problems.
    Denou E, Bruttin A, Barretto C, Ngom-Bru C, Brüssow H, Zuber S.
    Virology; 2009 May 25; 388(1):21-30. PubMed ID: 19339031
    [Abstract] [Full Text] [Related]

  • 6. Low-temperature T4-like coliphages vB_EcoM-VR5, vB_EcoM-VR7 and vB_EcoM-VR20.
    Kaliniene L, Klausa V, Truncaite L.
    Arch Virol; 2010 Jun 25; 155(6):871-80. PubMed ID: 20361343
    [Abstract] [Full Text] [Related]

  • 7. Human volunteers receiving Escherichia coli phage T4 orally: a safety test of phage therapy.
    Bruttin A, Brüssow H.
    Antimicrob Agents Chemother; 2005 Jul 25; 49(7):2874-8. PubMed ID: 15980363
    [Abstract] [Full Text] [Related]

  • 8. T4-like Escherichia coli phages from the environment carry blaCTX-M.
    Mohan Raj JR, Vittal R, Huilgol P, Bhat U, Karunasagar I.
    Lett Appl Microbiol; 2018 Jul 25; 67(1):9-14. PubMed ID: 29675838
    [Abstract] [Full Text] [Related]

  • 9. Serotypes and virutypes of enteropathogenic and enterohaemorrhagic Escherichia coli strains from stool samples of children with diarrhoea in Germany.
    Kozub-Witkowski E, Krause G, Frankel G, Kramer D, Appel B, Beutin L.
    J Appl Microbiol; 2008 Feb 25; 104(2):403-10. PubMed ID: 17887989
    [Abstract] [Full Text] [Related]

  • 10. The genome of the pseudo T-even bacteriophages, a diverse group that resembles T4.
    Monod C, Repoila F, Kutateladze M, Tétart F, Krisch HM.
    J Mol Biol; 1997 Mar 28; 267(2):237-49. PubMed ID: 9096222
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Detection of Escherichia coli with fluorescent labeled phages that have a broad host range to E. coli in sewage water.
    Namura M, Hijikata T, Miyanaga K, Tanji Y.
    Biotechnol Prog; 2008 Mar 28; 24(2):481-6. PubMed ID: 18225914
    [Abstract] [Full Text] [Related]

  • 13. Shiga toxin-negative attaching and effacing Escherichia coli: distinct clinical associations with bacterial phylogeny and virulence traits and inferred in-host pathogen evolution.
    Bielaszewska M, Middendorf B, Köck R, Friedrich AW, Fruth A, Karch H, Schmidt MA, Mellmann A.
    Clin Infect Dis; 2008 Jul 15; 47(2):208-17. PubMed ID: 18564929
    [Abstract] [Full Text] [Related]

  • 14. In vivo replication of T4 and T7 bacteriophages in germ-free mice colonized with Escherichia coli.
    Weiss M, Denou E, Bruttin A, Serra-Moreno R, Dillmann ML, Brüssow H.
    Virology; 2009 Oct 10; 393(1):16-23. PubMed ID: 19699505
    [Abstract] [Full Text] [Related]

  • 15. From bench to bed and back again: phage therapy of childhood Escherichia coli diarrhea.
    Sarker SA, Brüssow H.
    Ann N Y Acad Sci; 2016 May 10; 1372(1):42-52. PubMed ID: 27197768
    [Abstract] [Full Text] [Related]

  • 16. Molecular detection of verotoxin-producing Escherichia coli isolates in stool samples from patients with diarrhea.
    Usein CR, Tatu-Chiţoiu D, Palade AM, Ciontea S, Condei M, Nica M, Damian M.
    Roum Arch Microbiol Immunol; 2008 May 10; 67(1-2):17-22. PubMed ID: 19284162
    [Abstract] [Full Text] [Related]

  • 17. Coverage of diarrhoea-associated Escherichia coli isolates from different origins with two types of phage cocktails.
    Bourdin G, Navarro A, Sarker SA, Pittet AC, Qadri F, Sultana S, Cravioto A, Talukder KA, Reuteler G, Brüssow H.
    Microb Biotechnol; 2014 Mar 10; 7(2):165-76. PubMed ID: 24528873
    [Abstract] [Full Text] [Related]

  • 18. Oral application of Escherichia coli bacteriophage: safety tests in healthy and diarrheal children from Bangladesh.
    Sarker SA, Berger B, Deng Y, Kieser S, Foata F, Moine D, Descombes P, Sultana S, Huq S, Bardhan PK, Vuillet V, Praplan F, Brüssow H.
    Environ Microbiol; 2017 Jan 10; 19(1):237-250. PubMed ID: 27750388
    [Abstract] [Full Text] [Related]

  • 19. Prevalence of viral, bacterial and parasitic enteropathogens among young children with acute diarrhoea in Jeddah, Saudi Arabia.
    el-Sheikh SM, el-Assouli SM.
    J Health Popul Nutr; 2001 Mar 10; 19(1):25-30. PubMed ID: 11394180
    [Abstract] [Full Text] [Related]

  • 20. Phenotypic and molecular characterization of clinically isolated Escherichia coli.
    Vaishnavi C, Kaur S, Beutin L, Krueger U.
    Indian J Pathol Microbiol; 2010 Mar 10; 53(3):503-8. PubMed ID: 20699512
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.